Business Wire

Boomi and AWS Announce Strategic Collaboration to Transform Enterprise AI Integration, Automation, and SAP Cloud Migration

14.5.2025 15:00:00 CEST | Business Wire | Press release

Share

Boomi™, the leader in AI-driven automation, today announced a multi-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS) to help customers build, manage, monitor and govern generative artificial intelligence (AI) agents across enterprise operations. Additionally, the SCA will aim to help customers accelerate SAP migrations from on-premises to AWS.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514456908/en/

Boomi and AWS Announce Strategic Collaboration to Transform Enterprise AI Integration, Automation, and SAP Cloud Migration

Enterprise organizations today struggle with fragmented AI agent management across multiple platforms and environments, incurring potential security risks and operational inefficiencies. As AI agent adoption accelerates, organizations need a trusted way to monitor, secure, and optimize their AI investments across their diverse technology landscape.

By integrating Amazon Bedrock — a fully managed service for building and scaling generative AI applications, including access to the broadest selection of fully managed models from leading AI companies — with the Boomi Agent Control Tower, a centralized management solution for deploying, monitoring, and governing AI agents across hybrid and multi-cloud environments, customers can easily discover, build, and manage agents executing in their AWS accounts, while also maintaining visibility and control over agents running in other cloud provider or third-party environments. Through a single API, Amazon Bedrock provides a broad set of capabilities to build generative AI applications with security, privacy, and responsible AI in mind, including support for Model Context Protocol (MCP), a new open standard that enables developers to build secure, two-way connections between their data and AI-powered tools. MCP enables agents to effectively interpret and work with ERP data while complying with data governance and security requirements.

"Our Strategic Collaboration Agreement with AWS comes at a critical inflection point where enterprise AI adoption requires a delicate balance between innovation and governance," said Steve Lucas, Chairman and CEO at Boomi. "By integrating Amazon Bedrock's powerful generative AI capabilities with Boomi's Agent Control Tower, we're giving organizations unprecedented visibility and control across their entire AI ecosystem while simultaneously accelerating their critical SAP workload migrations to AWS. This partnership enables enterprises to confidently scale their AI initiatives with the security, compliance, and operational excellence their business demands."

“As we've worked with thousands of customers adopting generative AI, one thing has become clear—enterprises need robust solutions to effectively deploy, monitor, and govern AI agents across their technology environments,” said Rahul Pathak, VP, Data & AI GTM at AWS. “Amazon Bedrock provides customers with choice—the most comprehensive selection of foundation models and built-in governance capabilities. When you combine this with Boomi's Agent Control Tower providing centralized visibility and control, customers get what they need to innovate confidently while maintaining security and compliance. This collaboration brings together complementary strengths so customers can move quickly from proof-of-concept to production while meeting their business requirements.”

“As we expand AI-driven automation across our business, Boomi and AWS are essential partners enabling us to securely manage complexity and scale innovation,” said Amit Sinha, President & Co-Founder of WorkSpan. “Utilizing Boomi’s integration capabilities combined with AWS infrastructure, we seamlessly connect diverse systems, accelerate SAP and AI initiatives, and maintain essential visibility and governance across our technology landscape—significantly enhancing our ability to innovate quickly and confidently.”

The collaboration will introduce several strategic joint initiatives, including:

  • Agent Control Tower - Integrated with Amazon Bedrock, Boomi’s Agent Control Tower, part of Boomi Agentstudio (formerly Boomi AI Studio), provides holistic multi-cloud governance for AI agents. Organizations gain comprehensive visibility, proactive monitoring, and control of both Boomi-authored and third-party AI agents. This solution is critical for securely scaling AI initiatives across on-premises, public, or hybrid cloud environments, reducing complexity and ensuring enterprise-grade security and compliance.
  • Enhanced Agent Designer - Boomi’s low-code Agent Designer, now integrated with Amazon Q index, allows rapid creation of AI agents with deep contextual understanding and smarter model selection. Enterprises can build, train, and deploy intelligent agents that leverage Amazon Q index for improved relevance and performance—and then manage them at scale via Boomi’s multi-platform Agent Control Tower.
  • New Native AWS Connectors and Boomi forSAP - As part of its SCA with AWS, Boomi has introduced new native connectors for AWS Lambda, Amazon Bedrock, Amazon DynamoDB, and the Amazon Selling Partner Appstore. These connectors enable seamless integration across AWS services, supporting use cases from serverless computing to generative AI and e-commerce. Also part of the broader SCA collaboration, Boomi for SAP provides SAP-certified native integration that simplifies and accelerates connectivity between SAP and non-SAP systems, reduces integration time, and supports cloud migration with modern ELT capabilities powered by the Rivery acquisition. Organizations can efficiently move SAP data into any AWS-powered data warehouse or data lake to enable real-time analytics and AI. Together, Boomi and AWS empower organizations to connect SAP to non-SAP applications, move data seamlessly to the cloud, and fuel AI and analytics initiatives—maximizing the value of their technology investments.

Boomi Validated as AWS Generative AI Competency Partner

Boomi also announced it achieved the AWS Generative AI Competency - a specialization that recognizes Boomi as an AWS Partner that helps customers and the AWS Partner Network drive the advancement of services, tools, and infrastructure pivotal for implementing generative AI technologies. As of May 2025, this marks Boomi’s fifth AWS Competency, demonstrating Boomi’s leadership in building generative AI applications using AWS technologies such as Amazon Bedrock, Amazon Q, and Amazon SageMaker. This recognition reflects Boomi’s proven field expertise and technical best practices, enabling customers to innovate confidently with next-generation AI solutions at scale.

Additional Resources

About Boomi

Boomi, the leader in AI-driven automation, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.

© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250514456908/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye